312 related articles for article (PubMed ID: 18035325)
1. B cells in SLE: different biological drugs for different pathogenic mechanisms.
Diamanti AP; Rosado MM; Carsetti R; Valesini G
Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
[TBL] [Abstract][Full Text] [Related]
2. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
Sousa E; Isenberg D
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
[TBL] [Abstract][Full Text] [Related]
3. B cell modulation strategies in autoimmunity: the SLE example.
Rosado MM; Diamanti AP; Capolunghi F; Carsetti R
Curr Pharm Des; 2011; 17(29):3155-65. PubMed ID: 21864265
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus in children: current and emerging therapies.
Macdermott EJ; Adams A; Lehman TJ
Lupus; 2007; 16(8):677-83. PubMed ID: 17711907
[TBL] [Abstract][Full Text] [Related]
5. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
Levesque MC; St Clair EW
J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin 10 in disseminated lupus erythematosus].
Emilie D
J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
[TBL] [Abstract][Full Text] [Related]
7. B-cell-directed therapies in systemic lupus erythematosus.
Tieng AT; Peeva E
Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
[TBL] [Abstract][Full Text] [Related]
8. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
9. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
Murdaca G; Colombo BM; Puppo F
Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
[TBL] [Abstract][Full Text] [Related]
10. New treatments for SLE: cell-depleting and anti-cytokine therapies.
Anolik JH; Aringer M
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
[TBL] [Abstract][Full Text] [Related]
11. The immunological basis of B-cell therapy in systemic lupus erythematosus.
Mok MY
Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
13. B cell targeted therapies in autoimmune diseases.
Isenberg DA
J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.
Sutter JA; Kwan-Morley J; Dunham J; Du YZ; Kamoun M; Albert D; Eisenberg RA; Luning Prak ET
Clin Immunol; 2008 Mar; 126(3):282-90. PubMed ID: 18226586
[TBL] [Abstract][Full Text] [Related]
15. Antibody-based therapies in systemic lupus erythematosus.
Iikuni N; La Cava A
Mini Rev Med Chem; 2009 Jun; 9(7):829-46. PubMed ID: 19519508
[TBL] [Abstract][Full Text] [Related]
16. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
17. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
Dooley MA; Ginzler EM
Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
[TBL] [Abstract][Full Text] [Related]
18. B cell biology and dysfunction in SLE.
Anolik JH
Bull NYU Hosp Jt Dis; 2007; 65(3):182-6. PubMed ID: 17922667
[TBL] [Abstract][Full Text] [Related]
19. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
Albert D; Dunham J; Khan S; Stansberry J; Kolasinski S; Tsai D; Pullman-Mooar S; Barnack F; Striebich C; Looney RJ; Prak ET; Kimberly R; Zhang Y; Eisenberg R
Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
[TBL] [Abstract][Full Text] [Related]
20. Repeated B cell depletion in treatment of refractory systemic lupus erythematosus.
Ng KP; Leandro MJ; Edwards JC; Ehrenstein MR; Cambridge G; Isenberg DA
Ann Rheum Dis; 2006 Jul; 65(7):942-5. PubMed ID: 16269424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
